Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Managed Health Care Associates (MHA) does not develop therapeutics but provides group purchasing, software solutions, and business support to alternate site healthcare providers such as long-term care pharmacies, infusion and specialty pharmacies, home medical equipment providers, assisted living facilities, and skilled nursing facilities. It has evolved into the largest alternate site GPO in the US with significant software/data analytics capabilities[1][2][3][5].
The company was acquired by Roper Industries (now Roper Technologies) in May 2013 for $1 billion[5]. It remains active as an independent subsidiary focused on supporting healthcare provider operations outside of acute care hospitals.
MHA has played key roles during public health events (e.g., COVID vaccination network administration for LTC pharmacy network)[2].
No clinical pipeline or therapeutic programs exist.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Managed Health Care Associates.